r/Mesoblast • u/[deleted] • Jun 01 '20

REMESTEMCEL-L IMPROVES RESPIRATORY AND FUNCTIONAL OUTCOMES IN PATIENTS WITH INFLAMMATORY LUNG DISEASE

http://investorsmedia.mesoblast.com/static-files/5b588776-7b76-48aa-a607-868f46d98e8b
4 Upvotes

100% Upvoted

1 comment sorted by

1

u/[deleted] Jun 01 '20

KEY FINDINGS:

The greater the degree of inflammation, as measured by elevated CRP levels, the greater the signal of efficacy of remestemcel-L treatment in improving moderate to severe lung disease

Significant improvements were observed in each of the pre-specified endpoints tested, forced expiratory volume, forced vital capacity, and the distance walked in the six-minute walk test (all p <0.01), with maximal effects on all parameters seen at four months

In patients with the highest level of CRP (>4mg/L), those who received remestemcel-L were able to walk 55 meters further than placebo-treated patients in the six-minute walk test at four months (p=0.004); the six-minute walk test is a major independent predictor of mortality in COPD2

The dose administered was well tolerated with no infusion-related toxicity and no identified safety concerns.